vs
Side-by-side financial comparison of QIAGEN N.V. (QGEN) and Revolution Medicines, Inc. (RVMD). Click either name above to swap in a different company.
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located ...
Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 | ||
| Q4 23 | — | $742.0K | ||
| Q3 23 | — | $0 | ||
| Q2 23 | — | $3.8M | ||
| Q1 23 | — | $7.0M |
| Q4 24 | — | $-194.6M | ||
| Q3 24 | — | $-156.3M | ||
| Q2 24 | — | $-133.2M | ||
| Q1 24 | — | $-116.0M | ||
| Q4 23 | — | $-161.5M | ||
| Q3 23 | — | $-108.4M | ||
| Q2 23 | — | $-98.3M | ||
| Q1 23 | — | $-68.1M |
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | -24256.5% | ||
| Q3 23 | — | — | ||
| Q2 23 | — | -2845.1% | ||
| Q1 23 | — | -1071.5% |
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | -21770.5% | ||
| Q3 23 | — | — | ||
| Q2 23 | — | -2570.6% | ||
| Q1 23 | — | -970.9% |
| Q4 24 | — | $-1.13 | ||
| Q3 24 | — | $-0.94 | ||
| Q2 24 | — | $-0.81 | ||
| Q1 24 | — | $-0.70 | ||
| Q4 23 | — | $-1.23 | ||
| Q3 23 | — | $-0.99 | ||
| Q2 23 | — | $-0.92 | ||
| Q1 23 | — | $-0.72 |
